AKT1 and Insulin resistance: In addition, it improved the insulin resistance by inhibiting the expression of the phosphorylated insulin receptor substrate-1 (IRS-1), and by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB or Akt) pathway in IR-HepG2 cells.